Application of superresolution ultrasound imaging for assessing microvascular structure and hemodynamic changes in rabbit VX2 models [0.03%]
超分辨率超声成像技术评价兔VX2肿瘤模型微血管结构及血流动力学改变的应用研究
Chaonan Chen,Qianqian Zeng,Sitong Chen et al.
Chaonan Chen et al.
Background: Noninvasive and functional tumor vascular system imaging at the microscopic scale is greatly significant. Using animal models, we investigated the feasibility of using superresolution ultrasound (SR-US) imagin...
Efficacy and safety of the CT-guided co-ablation system in the treatment of malignant melanoma with hepatic metastasis [0.03%]
CT引导下联合消融系统治疗恶性黑色素瘤肝转移疗效及安全性分析
Xueyan Li,Jiaxin Chen,Gulijiayina Nuerhashi et al.
Xueyan Li et al.
Purpose: To evaluate the efficacy and safety of computed tomography (CT)-guided co-ablation in patients with hepatic metastases from malignant melanoma. M...
Improvement and application of supine position components for lung tumor microwave ablation [0.03%]
改良并应用于肺癌微波消融的仰卧位组件
Yanan Zhang,Yue Li,Qiuying Wei et al.
Yanan Zhang et al.
Objective: This study aimed to evaluate the safety and efficacy of improved supine positioning components for lung tumor microwave ablation (MWA), with the goal of enhancing surgical efficiency, reducing complications, an...
Randomized Controlled Trial
Journal of cancer research and therapeutics. 2025 Sep 1;21(4):885-891. DOI:10.4103/jcrt.jcrt_108_25 2025
What is the optimal first-line regimen for patients with advanced HER2-positive breast cancer: A systematic review and network meta-analysis [0.03%]
晚期HER2阳性乳腺癌一线治疗的最佳方案是什么？系统评价和网络meta分析
Chenxi Wei,Qi Zheng,Xinchun Ma et al.
Chenxi Wei et al.
Background: The advent of anti-HER2 agents, such as trastuzumab, pertuzumab, and trastuzumab emtansine (T-DM1), has significantly improved survival in metastatic HER2-positive breast cancer (BC). Multiple anti-HER2 combin...
Effect of radical radiotherapy dose on the prognosis of limited-stage thoracic small cell carcinoma of the esophagus: A multicenter retrospective trial from China (CHiSCEC) [0.03%]
中国多中心限局期胸段小细胞食管癌放疗剂量疗效回顾性研究(CHiSCEC)
Zhanyuan Li,Qi Zhang,Qifeng Wang et al.
Zhanyuan Li et al.
Background: The optimal radiation dose for the treatment of small cell carcinoma of the esophagus (SCEC) has not been established. This study aimed to investigate the treatment outcomes and toxicities in patients with lim...
Development and validation of a risk signature based on disulidptosis-related ferroptosis genes in ovarian cancer [0.03%]
基于铁死亡相关蛋白酶体通路基因的风险信号在卵巢癌中的发展及验证
Yaxin Sun,Lidong Liu,Fatao Guo et al.
Yaxin Sun et al.
Background: Disulfidptosis and ferroptosis, newly identified forms of cell death, have attracted widespread attention; however, their relationship with ovarian cancer (OC) prognosis remains unclear. ...
Comparing long-term survival prognosis with surgery-based systemic treatment of gastrointestinal stromal tumors: A population-based study [0.03%]
基于手术的系统治疗胃肠间质肿瘤的长期生存预后比较：一项基于人群的研究
Fuli Gao,Xiaodan Xu
Fuli Gao
Background: To date, the optimal sequence of systemic therapy (ST) and surgical resection for gastrointestinal stromal tumors (GISTs) remains unknown. This study aimed to compare the long-term outcomes of different ST app...
Comparison of postoperative adjuvant therapy for early-stage cervical cancer: A surveillance, epidemiology, and end results analysis [0.03%]
早期宫颈癌术后辅助治疗的比较：一项监测、流行病学和最终结果分析
Le Zhou,Yu Bai,Peng Diao et al.
Le Zhou et al.
Objectives: To compare the effects of different adjuvant treatments for different pathological types of early-stage cervical cancer post-surgery. Material...
Combination of hepatic artery infusion chemotherapy and PD1 immune checkpoint inhibitor improve survival in patients with KRAS-mutated unresectable colorectal liver metastases: A propensity score matching study [0.03%]
肝动脉灌注化疗联合PD1免疫检查点抑制剂可改善KRAS突变型不可切除结直肠癌肝转移患者的生存率：倾向性匹配研究
Hao Hu,Fulei Gao,Maohuan Lin et al.
Hao Hu et al.
Objective: This study examined the effect of hepatic arterial infusion chemotherapy (HAIC) plus programmed death 1 inhibitors (HAICPs) in patients with unresected colorectal cancer liver metastases (UCRLM) with and withou...
Construction and application of a mortality risk prediction model for patients with lung squamous cell carcinoma: A competing risk analysis [0.03%]
肺鳞癌患者死亡风险预测模型的构建及应用：竞争风险分析
Qin Wang,Qianqian Wang,Di Wang et al.
Qin Wang et al.
Background: Lung squamous cell carcinoma (LUSC) is the dominant histological subtype of lung cancer, accounting for 30% of all cases. Most patients develop distant metastases by the time they are diagnosed with the diseas...